The KCNJ11 E23K and ABCC8 exon 31 variants contribute to susceptibility to type 2 diabetes, glucose intolerance and altered insulin secretion in a Russian population

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 3, 2008, Pages 185-191

  Chistiakov, Dimitry A ^a   Potapov, Viktor A ^a   Khodirev, Dimitry S ^a   Shamkhalova, Minara S ^b   Shestakova, Marina V ^b   Nosikov, Valery V ^a  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

ABCC8; Glucose tolerance; Insulin secretion; KCNJ11; Russian population; Susceptibility; Type 2 diabetes

Indexed keywords

ADENOSINE; GENOMIC DNA; GLUCOSE; GUANOSINE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CHI SQUARE TEST; CONTROLLED STUDY; DIET RESTRICTION; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE INTOLERANCE; HETEROZYGOTE; HOMEOSTASIS; HOMOZYGOSITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL FUNCTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; RUSSIAN FEDERATION; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

EID: 47649131870     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2008.04.002     Document Type: Article

References (38)

1. + channels. Prog Biophys Mol Biol 81 (2003) 133-176
2. Aguilar-Bryan L., and Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20 (1999) 101-135
3. Smith A.J., Taneja T.K., Mankouri J., and Sivaprasadao A. Molecular cell biology of KATP channels: implications for neonatal diabetes. Expert Rev Mol Med 9 (2007) 1-17
4. Nichols C.G., Koster J.C., and Remedi M.S. β-Cell hyperexcitability: from hyperinsulinism to diabetes. Diabetes Obes Metab 9 (2007) 81-88
5. Schwanstecher C., Meyer U., and Schwanstecher M. KIR6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic β-cell ATP-sensitive K channels. Diabetes 51 (2002) 875-879
6. + channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia 41 (1998) 1511-1515
7. Gloyn A.L., Hashim Y., Ashcroft S.J., Ashfield R., Wiltshire S., Turner R.C., et al. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med 18 (2003) 206-212
8. Gloyn A.L., Weedon M.N., Owen K.R., Turner M.J., Knight B.A., Hitman G., et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52 (2003) 568-572
9. Florez J.C., Jablonski K.A., Kahn S.E., Franks P.W., Dabelea D., Hamman R.F., et al. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 56 (2007) 531-536
10. Sakamoto Y., Inoue H., Keshavarz P., Miyawaki K., Yamaguchi Y., Moritani M., et al. SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. J Hum Genet 52 (2007) 781-793
11. Doi Y., Kubo M., Ninomiya T., Yonemeto K., Iwase M., Arima H., et al. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: the Hisayama Study. Diabetes 56 (2007) 2829-2833
12. Shaat N., Ekelund M., Lernmark A A., Ivarsson S., Almgren P., Berntorp K., et al. Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Diabetologia 48 (2005) 2544-2551
13. Nielsen E.M., Hansen L., Carstensen B., Echwald S.M., Drivsholm T., Glumer C., et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52 (2003) 573-577
14. Florez J.C., Burtt N., de Bakker P.I.W., Almgren P., Tuomi T., Holmkvist J., et al. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 53 (2004) 1360-1368
15. Lyssenko V., Almgren P., Anevski D D., Orho-Melander M., Sjogren M., Saloranta C., et al. Genetic prediction of future type 2 diabetes. PLoS Med 2 (2005) e345
16. + channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabet Med 22 (2005) 590-598
17. Laukkanen O., Pihlajamaki J., Lindstrom J., Eriksson J., Valle T.T., Hamalainen H., et al. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89 (2004) 6286-6290
18. + channels. Diabetes 54 (2005) 2070-2079
19. Seghers V., Nakazaki M., DeMayo F., Aguilar-Bryan L., and Bryan J. Sur1 knockout mice. A model for KATP channel-independent regulation of insulin secretion. J Biol Chem 275 (2000) 9270-9277
20. Shiota C., Larsson O., Shelton K.D., Shiota M., Efanov A.M., Hoy M., et al. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem 277 (2002) 37176-37183
21. Doliba N.M., Qin W., Vatamaniuk M.Z., Li C., Zelent D., Hajafi H., et al. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine. Am J Physiol Endocrinol Metab 286 (2004) E834-E843
22. Altshuler D., Hirschhorn J.N., Klannemark M M., Lindgren C.M., Vohl M.C., Nemesh J., et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 (2000) 76-80
23. Rissanen J., Markkanen A., Karkkainen P., Pihlajamaki J., Kekalainen P., Mykkanen L., et al. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 23 (2000) 70-73
24. Hansen T., Ambye L., Grarup N., Hansen L., Echwald S.M., Ferrer J., et al. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus. Diabetologia 44 (2001) 1330-1334
25. Elbein S.C., Sun J., Scroggin E., Teng K., and Hasstedt S.J. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1 alpha genes. Diabetes Care 24 (2001) 472-478
26. Hart L.M., Dekker J.M., van Haeften T.W., Ruige J.B., Stehouwer C.D., Erkelens D.W., et al. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus. Diabetologia 43 (2000) 515-519
27. Barroso I., Luan J., Middelberg R.P.S., Harding A.H., Franks P.W., Jakes R.W., et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol 1 (2003) 41-55
28. Reis A.F., Ye W.Z., Dubois-Laforgue D., Bellanne-Chantelot C., Timsit J., and Velho G. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Hum Genet 107 (2000) 138-144
29. Goksel D.L., Fischbach K., Duggirala R., Mitchell B.D., Aguilar-Bryan L., Blangero J., et al. Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR1 gene variant and hyperinsulinemia. Hum Genet 103 (1998) 280-285
30. Kilpelainen T.O., Lakka T.A., Laaksonen DE D.E., Laukkanen O., Lindstrom J., Eriksson J.G., et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 31 (2007) 264-272
31. WHO. Diabetes mellitus. Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser. 1985;727:1-113.
32. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
33. Bland J.M., and Altman D.G. The odds ratio. BMJ 320 (2000) 1468-11468
34. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Jarvinen H., Van Haeffen T., et al. Use of the oral glucose tolerance test to access insulin release and insulin sensitivity. Diabetes Care 23 (2000) 295-301
35. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
36. Love-Gregory L., Wasson J., Lin J., Skolnick G., Suarez B., and Permutt M.A. E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of type II diabetes in Caucasians as the PPARγ Pro12Ala variant. Diabetologia 46 (2003) 136-137
37. Tschritter O., Stimvoll M., Machicao F., Holzwarth M., Weisser M., Maerker E., et al. The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (Kir6.2) gene secretion is associated with impaired glucagon suppression in response to hyperglycemia. Diabetes 51 (2002) 3135-3138
38. + channels. Eur J Physiol 453 (2007) 703-718